診斷性試驗和策略的證據質量和推薦強度的分級_《中國循證醫學雜志》

作者：

Holger J Schnemann , Andrew D Oxman , Jan Brozek , Paul Glasziou , Roman Jaeschke , Gunn E Vist , John W Williams Jr , Regina Kunz , Jonathan Craig , Victor M Montori , Patrick Bossuyt , Gordon H Guyatt , 代表GRADE工作組

關鍵詞：

DOI：

10.7507/1672-2531.20090093

視頻：

導出 下載 收藏 掃碼 引用

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

引用本文： Holger J Schnemann,Andrew D Oxman,Jan Brozek,Paul Glasziou,Roman Jaeschke,Gunn E Vist,John W Williams Jr,Regina Kunz,Jonathan Craig,Victor M Montori,Patrick Bossuyt,Gordon H Guyatt,代表GRADE工作組. 診斷性試驗和策略的證據質量和推薦強度的分級. 中國循證醫學雜志, 2009, 09(5): 503-508. doi: 10.7507/1672-2531.20090093 復制

1.	Deeks J. Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests. BMJ, 2001, 323(7305): 157-162.
2.	Oxman A, Guyatt G. Guidelines for reading literature reviews. CMAJ, 1988, 138(8): 697-703.
3.	Mulrow C, Linn W, Gaul M, et al. Assessing quality of a diagnostic test evaluation. J Gen Intern Med, 1989, 4(4): 288-295.
4.	Guyatt G, Montori V, Devereaux P, et al. Patients at the center: in our practice, and in our use of language. ACP Journal Club, 140(1): A11-2.
5.	Hamon M, Biondi-Zoccai G, Malagutti P, et al. Diagnostic performance of multislice spiral computed tomography of coronary arteries as compared with conventional invasive coronary angiography: a meta-analysis. Journal of the American College of Cardiology, 2006, 48(9): 1896-1910.
6.	Bossuyt P, Irwig L, Craig J, et al. Comparative accuracy: assessing new tests against existing diagnostic pathways. BMJ, 2006, 332(7549): 1089-1092.
7.	Bossuyt P, Lijmer J, Mol B. Randomised comparisons of medical tests: sometimes invalid, not always efficient. Lancet, 2000, 356(9244): 1844-1847.
8.	Mueller C, SCHOLER A, LAULE-KILIAN K, et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med, 2004, 350(7): 647-654.
9.	Moe G, Howlett J, Januzzi J, et al. N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study. Circulation, 2007, 115(24): 3103-3110.
10.	Worster A, Preyra I, Weaver B, et al. The accuracy of noncontrast helical computed tomography versus intravenous pyelography in the diagnosis of suspected acute urolithiasis: a meta-analysis. Annals of Emergency Medicine, 2002, 40(3): 280-286.
11.	Worster A, Haines T. Does replacing intravenous pyelography with noncontrast helical computed tomography benefit patients with suspected acute urolithiasis? Can Assoc Radiol J, 2002, 53(3): 144-148.
12.	Guyatt G, Oxman A, Kunz R, et al. Going from evidence to recommendations. BMJ, 2008, 336(7652): 1049-1051.
13.	Guyatt G, Oxman A, Kunz R, et al. What is" quality of evidence" and why is it important to clinicians? BMJ, 2008, 336(7651): 995-998.
14.	Lord S, Irwig L, Simes R. When is measuring sensitivity and specificity sufficient to evaluate a diagnostic test, and when do we need randomized trials? Annals of Internal Medicine, 2006, 144(11): 850-855.
15.	Maat-Kievit A, Vegter-van der Vlis M, Zoeteweij M, et al. Paradox of a better test for Huntington’s disease. Journal of Neurology, Neurosurgery, and Psychiatry, 2000, 69 (5): 579-583.
16.	Walker FO. Huntington’s disease. Semin Neurol, 2007, 27: 143-150.
17.	Almqvist E, Brinkman R, Wiggins S, et al. Psychological consequences and predictors of adverse events in the first 5 years after predictive testing for Huntington’s disease. Clinical Genetics, 2003, 64(4): 300-309.
18.	Rutjes A, Reitsma J, Di Nisio M, et al. Evidence of bias and variation in diagnostic accuracy studies. CMAJ, 2006, 174(4): 469-476.
19.	Lijmer J, Mol B, Heisterkamp S, et al. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA, 1999, 282(11): 1061-1066.
20.	Bossuyt P, Reitsma J, Bruns D, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Ann Intern Med, 2003, 138(1): 40-44.
21.	Whiting P, Rutjes A, Reitsma J, et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Medical Research Methodology, 2003, 3: 25.
22.	Whiting P, Weswood M, Rutjes A, et al. Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med Res Methodol, 2006, 6: 9.
23.	Atkins D, Best D, Briss P, et al. Grading quality of evidence and strength of recommendations. BMJ, 2004, 328(7454): 1490.
24.	Schünemann H, Jaeschke R, Cook D, et al. An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. American Journal of Respiratory and Critical Care Medicine, 2006, 174 (5): 605-614.
25.	Fletcher R. Carcinoembryonic antigen. Annals of Internal Medicine, 1986, 104(1): 66-73.
26.	Hlatky M, Pryor D, Harrell JR F, et al. Factors affecting sensitivity and specificity of exercise electrocardiography. Multivariable analysis. Am J Med, 1984, 77(1): 64-71.
27.	Levy D, Labib S, Anderson K, et al. Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation, 1990, 81(3): 815-820.

1. Deeks J. Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests. BMJ, 2001, 323(7305): 157-162.
2. Oxman A, Guyatt G. Guidelines for reading literature reviews. CMAJ, 1988, 138(8): 697-703.
3. Mulrow C, Linn W, Gaul M, et al. Assessing quality of a diagnostic test evaluation. J Gen Intern Med, 1989, 4(4): 288-295.
4. Guyatt G, Montori V, Devereaux P, et al. Patients at the center: in our practice, and in our use of language. ACP Journal Club, 140(1): A11-2.
5. Hamon M, Biondi-Zoccai G, Malagutti P, et al. Diagnostic performance of multislice spiral computed tomography of coronary arteries as compared with conventional invasive coronary angiography: a meta-analysis. Journal of the American College of Cardiology, 2006, 48(9): 1896-1910.
6. Bossuyt P, Irwig L, Craig J, et al. Comparative accuracy: assessing new tests against existing diagnostic pathways. BMJ, 2006, 332(7549): 1089-1092.
7. Bossuyt P, Lijmer J, Mol B. Randomised comparisons of medical tests: sometimes invalid, not always efficient. Lancet, 2000, 356(9244): 1844-1847.
8. Mueller C, SCHOLER A, LAULE-KILIAN K, et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med, 2004, 350(7): 647-654.
9. Moe G, Howlett J, Januzzi J, et al. N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study. Circulation, 2007, 115(24): 3103-3110.
10. Worster A, Preyra I, Weaver B, et al. The accuracy of noncontrast helical computed tomography versus intravenous pyelography in the diagnosis of suspected acute urolithiasis: a meta-analysis. Annals of Emergency Medicine, 2002, 40(3): 280-286.
11. Worster A, Haines T. Does replacing intravenous pyelography with noncontrast helical computed tomography benefit patients with suspected acute urolithiasis? Can Assoc Radiol J, 2002, 53(3): 144-148.
12. Guyatt G, Oxman A, Kunz R, et al. Going from evidence to recommendations. BMJ, 2008, 336(7652): 1049-1051.
13. Guyatt G, Oxman A, Kunz R, et al. What is" quality of evidence" and why is it important to clinicians? BMJ, 2008, 336(7651): 995-998.
14. Lord S, Irwig L, Simes R. When is measuring sensitivity and specificity sufficient to evaluate a diagnostic test, and when do we need randomized trials? Annals of Internal Medicine, 2006, 144(11): 850-855.
15. Maat-Kievit A, Vegter-van der Vlis M, Zoeteweij M, et al. Paradox of a better test for Huntington’s disease. Journal of Neurology, Neurosurgery, and Psychiatry, 2000, 69 (5): 579-583.
16. Walker FO. Huntington’s disease. Semin Neurol, 2007, 27: 143-150.
17. Almqvist E, Brinkman R, Wiggins S, et al. Psychological consequences and predictors of adverse events in the first 5 years after predictive testing for Huntington’s disease. Clinical Genetics, 2003, 64(4): 300-309.
18. Rutjes A, Reitsma J, Di Nisio M, et al. Evidence of bias and variation in diagnostic accuracy studies. CMAJ, 2006, 174(4): 469-476.
19. Lijmer J, Mol B, Heisterkamp S, et al. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA, 1999, 282(11): 1061-1066.
20. Bossuyt P, Reitsma J, Bruns D, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Ann Intern Med, 2003, 138(1): 40-44.
21. Whiting P, Rutjes A, Reitsma J, et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Medical Research Methodology, 2003, 3: 25.
22. Whiting P, Weswood M, Rutjes A, et al. Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med Res Methodol, 2006, 6: 9.
23. Atkins D, Best D, Briss P, et al. Grading quality of evidence and strength of recommendations. BMJ, 2004, 328(7454): 1490.
24. Schünemann H, Jaeschke R, Cook D, et al. An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. American Journal of Respiratory and Critical Care Medicine, 2006, 174 (5): 605-614.
25. Fletcher R. Carcinoembryonic antigen. Annals of Internal Medicine, 1986, 104(1): 66-73.
26. Hlatky M, Pryor D, Harrell JR F, et al. Factors affecting sensitivity and specificity of exercise electrocardiography. Multivariable analysis. Am J Med, 1984, 77(1): 64-71.
27. Levy D, Labib S, Anderson K, et al. Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation, 1990, 81(3): 815-820.

上一篇
建人工氣道患者氣管狹窄的病因分析及防治
下一篇
建人工氣道患者氣管狹窄的病因分析及防治

《中國循證醫學雜志》

診斷性試驗和策略的證據質量和推薦強度的分級

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

上一篇

下一篇

Format

Content

《中國循證醫學雜志》

診斷性試驗和策略的證據質量和推薦強度的分級

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

上一篇

下一篇

Format

Content

摘要全文圖表視頻參考文獻施引文獻補充材料